Lu Hong

Mr. Lu Hong

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LHLu Hong
Lu Hong
Zheng CaiZheng Cai
Zheng Cai
Ping HuPing Hu
Ping Hu
In the realm of modern therapeutics, the development of polymeric delivery vehicles has revolutionized drug administration, offering a sophisticated approach to controlled and sustained drug release

12 October 2024 in Acta Biomaterialia
Verified
Journal Article
Closed access
QHQingwei He
Qingwei He
LHLu Hong
Lu Hong
YCYuying Chen
Yuying Chen
HZHuiying Zeng
Huiying Zeng
Ping HuPing Hu
Ping Hu

31 July 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
钰陈钰滢 陈
钰滢 陈
HLHuangjie Lu
Huangjie Lu
QHQingwei He
Qingwei He
JYJie Yang
Jie Yang
LHLu Hong
Lu Hong
Ping HuPing Hu
Ping Hu
Accurately measuring drug and its release kinetics in both in vitro and in vivo environments is crucial for enhancing therapeutic effectiveness while minimizing potential side effects. Nevertheless, the real-time visualization of drug release from microspheres to monitor potential overdoses remains a challenge. The primary objective of this investigation was to employ fluorescence imaging for the real-time monitoring of drug release from microspheres in vitro, thereby simplifying the laborious analysis associated with the detection of drug release. Two distinct varieties of microspheres were fabricated, each encapsulating different drugs within PLGA polymers. Cy5 was selected as the donor, and Cy7 was selected as the acceptor for visualization and quantification of the facilitated microsphere drug release through the application of the fluorescence resonance energy transfer (FRET) principle. The findings from the in vitro experiments indicate a correlation between the FRET fluorescence alterations and the drug release profiles of the microspheres.

17 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
LHLu Hong
Lu Hong
XNXuyang Ning
Xuyang Ning
QHQingwei He
Qingwei He
QLQianyun Lei
Qianyun Lei
PHPing Hu
Ping Hu
YLYingzhen Liang
Yingzhen Liang
To overcome the poor bioaccessibility of Coenzyme Q10 (CoQ10), we developed a polyethylene glycol-based dripping pill (DP) solid dispersion system. The optimized formulation achieved an amorphous state, resulting in uniform morphology, significantly accelerated dissolution, and enhanced oral bioavailability compared to crystalline CoQ10. In an isoproterenol-induced oxidative cardiac stress model, CoQ10 DPs showed enhanced in vivo bioactivity by alleviating cardiac remodeling and oxidative injury. Mechanistically, the enhanced delivery interrupted the oxidative stress-inflammation loop, evidenced by the clearance of reactive oxygen species (ROS) and restoration of superoxide dismutase (SOD) activity. This study presents a robust formulation strategy to maximize the bioactivity of lipophilic nutrients for functional food applications.